General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-02 | 2024-03 | -1.35 | N/A | N/A | N/A |
2024-02-22 | 2023-12 | -1.47 | -1.46 | 0.01 | 0.68% |
2023-11-09 | 2023-09 | -1.52 | -1.38 | 0.14 | 9.21% |
2023-08-03 | 2023-06 | -1.32 | -1.4 | -0.08 | -6.06% |
2023-05-04 | 2023-03 | -1.41 | -1.17 | 0.24 | 17.02% |
2023-02-23 | 2022-12 | -1.4 | -1.4 | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-09-12 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-08-28 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-08-08 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-08-06 | Chardan Capital | Upgrade | Buy | Buy |
2023-08-06 | Canaccord Genuity | Upgrade | Buy | Buy |
2023-08-06 | Barclays | Upgrade | Overweight | Overweight |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-03-03 | BASTA JAMES EDMUND | General Counsel | 81.57K | Sale |
2023-10-30 | BHANJI MUNA | Director | 12.00K | Sale |
2024-03-03 | CLARK ELIANA | Chief Technology Officer | 71.47K | Sale |
2023-06-13 | COHEN FREDERICK E. M.D. PH.D. | Director | 41.72K | Stock Award(Grant) |
2023-06-13 | CROWLEY JOHN FRANCIS | Director | 11.72K | Stock Award(Grant) |
2024-02-29 | GODDARD GLENN G | Chief Financial Officer | 69.21K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-09-29 | ARK Investment Management, LLC | 9.95M | 314.58M | 11.24% |
2023-06-29 | Vanguard Group Inc | 8.19M | 333.79M | 9.25% |
2023-06-29 | Blackrock Inc. | 8.05M | 328.48M | 9.10% |
2023-06-29 | State Street Corporation | 3.49M | 142.44M | 3.95% |
2023-06-29 | Nikko Asset Management Americas, Inc. | 3.39M | 138.43M | 3.84% |
2023-06-29 | Sumitomo Mitsui Trust Holdings, Inc. | 3.39M | 138.43M | 3.84% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-09-29 | ARK ETF Tr-ARK Innovation ETF | 6.78M | 214.49M | 7.67% |
2023-06-29 | Vanguard Total Stock Market Index Fund | 2.62M | 107.02M | 2.97% |
2023-06-29 | Vanguard Small-Cap Index Fund | 2.16M | 88.16M | 2.44% |
2023-09-29 | ARK ETF Tr-ARK Genomic Revolution ETF | 2.03M | 64.22M | 2.30% |
2023-08-30 | iShares Russell 2000 ETF | 2.01M | 75.44M | 2.27% |
2023-08-30 | SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 1.62M | 60.77M | 1.83% |
Pay attention to the charts. If you’re curious about where price could be going. I encourage you to look at the daily chart on any equity and draw a vertical line on the daily close of these dates each month 9th, 10th or 11th, 19th 20th or 21st, 29th 30th or 31st paying close attention to January, April, July and October. Wall Street institutions favor working price around these dates for some odd reason. I hope this helps because it helped me see this price drop coming.
New CRISPR/Cas9 patent issued to Carribou Bio $CRBU
$CRBU
Take a look at Caribou Biosciences.
Leader in CRISPR Gene editing. Cure to all diseases.
Founded by Nobel winner Jennifer Doudna and CEO Rachel Haurwitz.
Market cap 1.3 Billion.
They have 14,453,932 shares of Intellia (NTLA). Worth $2.5 Billion alone. Check out filings:
https://www.sec.gov/edgar/browse/?CIK=1619856&owner=exclude
They have about $500 Million in cash from recent IPO.
Listen to The Code Breaker by Walter Isaacson on Audible. https://www.audible.com/pd?asin=179711705X&source_code=ASSORAP0511160006
Check out patents:
Working on cure for cancer.
This has potential for x 1000
Do your own due diligence.
Good luck
$CRBU
Take a look at Caribou Biosciences.
Leader in CRISPR Gene editing. Cure to all diseases.
Founded by Nobel winner Jennifer Doudna and CEO Rachel Haurwitz.
Market cap 1.3 Billion.
They have 14,453,932 shares of Intellia (NTLA). Worth $2.5 Billion alone. Check out filings:
https://www.sec.gov/edgar/browse/?CIK=1619856&owner=exclude
They have about $500 Million in cash from recent IPO.
Listen to The Code Breaker by Walter Isaacson on Audible. https://www.audible.com/pd?asin=179711705X&source_code=ASSORAP0511160006
Check out patents:
Working on cure for cancer.
This has potential for x 1000
Do your own due diligence.
Good luck
Never get into stocks until see it move up & down for three days or more. Regretting my impulses. Advice for those who want to scalp, Bc man oh man…my portfolio pretty zeroed out
What happen today? Bears pissed in
Closed above $152 on a red market day
Tells you $NTLA it’s all about latest technology!
110%%%%% Count on it ! mark my words
To shit w bears! $NTLA temporarily down Bc of Nasdaq and bear bitches shorting it. This stock has strength & research is valuable! Watch it break $200 again very sooon!!!
Folks pls read below & don’t let FUD of bears worry you, $NTLA solid como at!
Scientists believe Intellia’s in vivo gene-editing results open the door to treating a wider range of diseases, including HIV.
This is a BIG deal!
Intellia’s stock doubled in a matter of days after its announcement.
NTLA Soared Over 100% Last Week
NTLA gene editing stock chart
(Source: Bloomberg.)
But if you missed out on Intellia’s rise, there’s no need to sweat.
CRISPR gene editing is just a subset of the rapidly growing genomics market.
This industry is poised to more than triple between now and 2030.
F u @swollengoat …wife beater !
Assholes bears think entire Nasdaq tanking to lower $NTLA price for them bitches…..watch it will go beyond $200 & bite ur teddies
It’s gonna go up from here to $175 and then $200 $NTLA DONT listen to bears bullshit
Don’t listen to bears or any FUD! Just a matter of time before market turns green & $NTLA shoots above $190. Compare to rest, it’s price in range. Will never go below 165 …it’s just temporary Bc of all bad China, hacking news, etc …trying to shake off strong hands …hold apes!!
No one is selling at this pt Big investors holding loooooong Can’t hold company/Nasdaq down 4ever. Bears Go suck
Shut or block all bear bullshit here! It’s a meaningful therapy & company has bright future!
Bullish…..$NTLA co-founder won Nobel prize last year for finding 🧬 editing Only up baby!